Novo Nordisk joined the many pharmaceutical companies pushing back on government-negotiated drug pricing in the United States.

The FTC in September sued the three companies, which it says together administer 80% of all prescriptions in the U.S., ...

Fact checked by Nick Blackmer More people with type 1 diabetes are using GLP-1s like Ozempic and Zepbound, a new study ...

The FTC lawsuit accuses the PBMs of unfairly limiting access to insulin drugs with lower list prices and steering diabetes ...

Discover which herbs can naturally help regulate blood sugar levels. Learn which herbs work like insulin and how to safely ...

Insulin: In 2019, employer plan participants who used insulin spent an average of $82 per month out-of-pocket on their ...

Created in 1914, the FTC is tasked with stopping unfair trade practices — particularly those by big corporations that use ...

Ozempic and similar semaglutide-based medications have been hailed as miracle drugs. Known as GLP-1 (glucagon-like peptide-1) ...

How GLP-1 analogs are reshaping diabetes care and obesity treatment and unlocking potential in cardiovascular, inflammatory, ...

Five researchers have been jointly awarded one of this year's Breakthrough Prizes in Life Sciences for their contributions to ...

Two studies suggested the diabetes/weight-loss drug may have a beneficial side effect—but more work is needed to confirm this.